Search
for
Sort by
Research 301–330 of 1000+
- Synthesis and in Vitro Evaluation of 4-Substituted N-(1,1-Dimethylethyl)-3-oxo-4-androstene-17.beta.-carboxamides as 5.alpha.-Reductase Inhibitors and Antiandrogens
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- Fadrozole and finasteride exposures modulate sex steroid- and thyroid hormone-related gene expression in Silurana (Xenopus) tropicalis early larval development
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- 075 Clinical investigation of JAK inhibitor Tofacitinib in scarring alopecias
- Hormonal Influences on Women's Health and Athletic Performance: Insights into the Menstrual Cycle, Menopause, Contraception, and Anabolic Steroids
- Efficacy of Janus kinase inhibitors in adult patients with alopecia areata
- Midazolam Inhibits Hippocampal Long-Term Potentiation and Learning through Dual Central and Peripheral Benzodiazepine Receptor Activation and Neurosteroidogenesis
- Non-hemorrhage-related adverse effects of rivaroxaban
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- The relevance of using 5α-reductase inhibitors in the conservative management of benign prostatic hyperplasia: A review
- Molecular interactions of natural and synthetic steroids in female hamsters’ flank organs
- Neurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research
- Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors
- New 5?-reductase inhibitors: In vitro and in vivo effects
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- Janus Kinase inhibitors in dermatology: a review
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- Do 5α-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results
- Risk of Type 2 Diabetes Mellitus in New Users of 5-Alpha Reductase Inhibitors: A Nationwide Historical Cohort Study
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Persistent Erectile Dysfunction after Discontinuation of 5-Alpha Reductase Inhibitor Therapy in Rats Depending on the Duration of Treatment
- Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review